CWM
IRWD icon

CIBC World Markets’s Ironwood Pharmaceuticals IRWD Stock Holding History

CIBC World Markets’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$35.7K Buy
+10,585
New +$27.5K ﹤0.01% 1209
2025
Q2 		$14.1K Sell
19,714
-11,679
-37% -$9.17K ﹤0.01% 1541
2025
Q1 		$46.1K Buy
31,393
+18,153
+137% +$43.2K ﹤0.01% 1726
2024
Q4 		$58.7K Buy
+13,240
New +$53.7K ﹤0.01% 1252

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CIBC World Markets's IRWD Position: Q4 2025 in Review

CIBC World Markets opened a new position in Ironwood Pharmaceuticals (IRWD) in Q4 2025: 10,585 shares worth $35.7K. The stake represents ﹤0.01% of the portfolio and ranks #1209 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in IRWD as recently as Q2 2025.

CIBC World Markets first reported a position in IRWD in Q4 2024 and has held it in 4 quarters since. The position peaked at $58.7K in Q4 2024. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2025.

  • CIBC World Markets held 10,585 shares of Ironwood Pharmaceuticals worth $35.7K as of Q4 2025.
  • Ironwood Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Ironwood Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1209 holding.
  • CIBC World Markets first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Ironwood Pharmaceuticals position peaked at $58.7K in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.